Baidu
map

心血管

订阅

MedSci主页 / 所有栏目 / 心血管

肖婧教授专访-CKD早期筛查、诊断及防治指南2022年版解读

2023-06-09 网络 网络 发表于上海

糖尿病肾病
关注

CKD早期筛查、诊断及防治指南2022年版解读1-4合集

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2024-01-19 梅斯管理员 来自上海

    #糖尿病肾病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-09 1462a93dm22暂无昵称 来自江苏省

    ckd的病人越来越多

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-10 仁术2023

    不错，学习了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-10 ms4000000512201075 来自吉林省

    不错，学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-09 医鸣惊人 来自山西省

    认真学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-09 1209e435m98(暂无昵称) 来自浙江省

    学习了，谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2182631, encodeId=e6d22182631ec, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76760, encryptionId=b081e6760b8, topicName=糖尿病肾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Fri Jan 19 13:39:54 CST 2024, time=2024-01-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141919, encodeId=834821419197f, content=ckd的病人越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ecc5117360, createdName=1462a93dm22暂无昵称, createdTime=Fri Jun 09 18:12:47 CST 2023, time=2023-06-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2142005, encodeId=6c85214200502, content=不错，学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=仁术2023, createdTime=Sat Jun 10 09:22:57 CST 2023, time=2023-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141989, encodeId=1c49214198933, content=不错，学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b08e8469269, createdName=ms4000000512201075, createdTime=Sat Jun 10 07:24:48 CST 2023, time=2023-06-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2141948, encodeId=3db1214194837, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jun 09 22:33:31 CST 2023, time=2023-06-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2141942, encodeId=11d7214194219, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Jun 09 21:27:50 CST 2023, time=2023-06-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2141923, encodeId=38ab2141923dc, content=很专业，学到了，很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9428741691, createdName=ms5000001846373376, createdTime=Fri Jun 09 18:45:59 CST 2023, time=2023-06-09, status=1, ipAttribution=内蒙古)]
    2023-06-09 ms5000001846373376 来自内蒙古

    很专业，学到了，很实用

    0

相关资讯

王继光教授|高血压合并糖尿病肾病，如何选择降压治疗策略？

高血压既是糖尿病肾病的主要合并症，也是其重要的危险因素之一，而糖尿病肾病还可导致高血压的危害进一步加重。

病例分享：糖尿病肾病合并高血压的诊治

"高血压"病史6年余，血压最高达160/100mmHg，现规律口服"厄贝沙坦片0.15g日1"现血压控制尚可。

病例分享：高伴糖患者的血压治疗心得

二氢吡啶类CCB和ARB都是很常用的降压药物，广泛应用于临床，高血压患者往往同时合并多种病症，尤其是当合并糖尿病时，要同时考虑到两种疾病的特性选择更适合患者的治疗方案。

糖尿病患者的降压治疗策略

高血压常合并糖代谢异常。我国门诊高血压患者中24.3%合并糖尿病

优化非糖尿病CKD患者的抗高血压治疗

非糖尿病肾病抗高血压文献综述。

从检测指标到决策因子，社区MAU筛查势在必行

慢性肾脏病（CKD）是严重危害人类健康的常见慢性进展性疾病之一，由于预后不良及终末期治疗成本巨大，已经成为严重的公共卫生问题。早期筛查识别并及时干预治疗，可延缓CKD 病情进展，改善患者预后。但目前全

Baidu
map
Baidu
map
Baidu
map